Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
accumulation ratio | measure of exposure after repeated dosing relative to a stated earlier exposure | The reported accumulation ratio compares the same exposure metric across intervals. | Assessment | Drug concentrations, exposure and assay interpretation |
ACTH stimulation test | cortisol response measured before and after administration of synthetic ACTH | The ACTH stimulation test was reported with the assay and sampling schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
active moiety | component responsible for pharmacologic activity in context | The report specifies which active moiety the assay measures. | Assessment | Medication exposure, response and adverse-effect reasoning |
aliquot | a measured portion separated for testing | Reserve an aliquot for the additional assay requested by the laboratory. | Plan | Diagnostic procedures and specimen handling |
analytical interference | substance or sample property alters the reported measurement | Possible analytical interference was discussed with the laboratory before interpreting the value. | Assessment | Drug concentrations, exposure and assay interpretation |
antibody avidity | measure of the overall binding strength of an antibody population | Antibody avidity was reported with the assay-specific interpretation. | Objective | Molecular testing, serology and culture findings |
apparent oral clearance | apparent clearance after oral dosing, expressed relative to bioavailability | The model reports apparent oral clearance because absolute bioavailability was not measured. | Assessment | Drug concentrations, exposure and assay interpretation |
AUC extrapolated to infinity | total single-dose exposure estimated beyond the last sample using terminal decline | The AUC extrapolated to infinity includes a separately reported extrapolated portion. | Assessment | Drug concentrations, exposure and assay interpretation |
AUC to last measurable concentration | exposure integrated through the final quantifiable sample | The report gives AUC to last measurable concentration and identifies the final sample time. | Assessment | Drug concentrations, exposure and assay interpretation |
average steady-state concentration | average concentration over a dosing interval at steady state | The reported average steady-state concentration was derived from interval exposure and duration. | Assessment | Drug concentrations, exposure and assay interpretation |
between-method variability | differences attributable to the measurement methods used | The results were reviewed for between-method variability after the assay changed. | Assessment | Diagnostic reasoning and strength of evidence |
blood-to-plasma ratio | whole-blood concentration divided by plasma concentration | The reported blood-to-plasma ratio was specific to the assay and sampling conditions. | Assessment | Drug concentrations, exposure and assay interpretation |
calibration shift | systematic change in results related to measurement calibration | The laboratory reviewed for a calibration shift after the analyzer change. | Assessment | Drug concentrations, exposure and assay interpretation |
concentration-time profile | sequence of concentrations linked to actual sampling times | The concentration-time profile was reconstructed using the medication record and sample labels. | Assessment | Drug concentrations, exposure and assay interpretation |
context-sensitive half-time | time for concentration to fall by half after stopping an infusion of a specified duration | The context-sensitive half-time was interpreted in the context of the prolonged infusion. | Assessment | Drug concentrations, exposure and assay interpretation |
detectable | present above the detection threshold | Viral RNA detectable on today's assay. | Objective | Laboratory, imaging and test descriptors |
detection limit | lowest amount distinguishable from background under stated conditions | The report lists the assay's detection limit alongside the qualitative result. | Objective | Drug levels - analyte, specimen and reporting |
discordant filtration estimates | different approaches give materially different estimates of kidney filtration | Discordant filtration estimates were reviewed with body composition and assay timing. | Assessment | Renal syndromes, dialysis and volume assessment |
distribution half-life | time for the concentration contribution of the distribution phase to decrease by half | The early decline reflects the distribution half-life in the fitted two-compartment model. | Assessment | Drug concentrations, exposure and assay interpretation |
donor-specific antibody | recipient antibody reactive to an antigen from the organ donor | The donor-specific antibody was reported with specificity and assay information. | Assessment | Cancer, treatment response and transplant assessment |
donor chimerism | proportion or pattern of donor-derived cells after transplantation | Donor chimerism was followed using the specified cell population and assay. | Assessment | Cancer, treatment response and transplant assessment |
dose-normalized AUC | area under the concentration-time curve divided by the administered dose | The team compared dose-normalized AUC using the same AUC interval in both periods. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized peak | peak concentration divided by the dose used for that observation | The dose-normalized peak was interpreted with the formulation and sampling window. | Assessment | Drug concentrations, exposure and assay interpretation |
effective half-life | half-life used to describe accumulation or decline for the specified situation | The interpretation specifies how the effective half-life was estimated. | Assessment | Drug concentrations, exposure and assay interpretation |
erythrocyte partitioning | distribution of drug into red blood cells | The choice of whole blood as the specimen reflects erythrocyte partitioning. | Assessment | Drug concentrations, exposure and assay interpretation |